<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00067405</url>
  </required_header>
  <id_info>
    <org_study_id>R21AT000942-01A1</org_study_id>
    <secondary_id>Katz</secondary_id>
    <nct_id>NCT00067405</nct_id>
  </id_info>
  <brief_title>Intravenous Micronutrient Therapy (IVMT) for Fibromyalgia</brief_title>
  <official_title>Intravenous Micronutrient Therapy (IVMT) for Fibromyalgia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Center for Complementary and Integrative Health (NCCIH)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Center for Complementary and Integrative Health (NCCIH)</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if intravenous micronutrient therapy (IVMT) is&#xD;
      effective in the treatment of fibromyalgia, as assessed by validated functional and pain&#xD;
      measures.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      As per Brief Summary&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2004</start_date>
  <completion_date type="Actual">July 2007</completion_date>
  <primary_completion_date type="Actual">July 2007</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <enrollment>40</enrollment>
  <condition>Fibromyalgia</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intravenous micronutrient therapy</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          -  Meet the American College of Rheumatology criteria for Fibromyalgia diagnosis;&#xD;
&#xD;
          -  On no medication for Fibromyalgia other than acetaminophen, or willing to stop all&#xD;
             such medication for the duration of the study&#xD;
&#xD;
               -  Willing to stop all FMS medication for the duration of the study or be on a&#xD;
                  stable dose of such medication for at least 3 months&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  Other concurrent medical conditions such as rheumatologic disease, chronic infection,&#xD;
             untreated endocrine disorders, unstable seizures, psychiatric disorders, acute peptic&#xD;
             ulcer disease, congestive heart failure, chronic liver disorders and/or bleeding&#xD;
             problems&#xD;
&#xD;
               -  Allergy to thiamin&#xD;
&#xD;
          -  Unwilling to stop vitamin supplementation for the duration of the study&#xD;
&#xD;
               -  PLEASE NOTE: Travel to and accomodations at the study site can NOT be&#xD;
                  compensated. Anyone wishing to travel from outside of the study site's geographic&#xD;
                  area must do so at their own risk and expense.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Katz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Yale-Griffin Prevention Research Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Yale-Griffin Prevention Research Center</name>
      <address>
        <city>Derby</city>
        <state>Connecticut</state>
        <zip>06418</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2008</verification_date>
  <study_first_submitted>August 18, 2003</study_first_submitted>
  <study_first_submitted_qc>August 19, 2003</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 20, 2003</study_first_posted>
  <last_update_submitted>April 21, 2008</last_update_submitted>
  <last_update_submitted_qc>April 21, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 22, 2008</last_update_posted>
  <keyword>Fibromyalgia</keyword>
  <keyword>Intravenous micronutrient therapy</keyword>
  <keyword>IVMT</keyword>
  <keyword>alternative medicine</keyword>
  <keyword>complementary medicine</keyword>
  <keyword>vitamins</keyword>
  <keyword>vitamin supplements</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibromyalgia</mesh_term>
    <mesh_term>Myofascial Pain Syndromes</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Micronutrients</mesh_term>
    <mesh_term>Trace Elements</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

